(Q34942903)

5 August 2017

1 reference

title

Statins as anti-inflammatory agents (English)

1 reference

5 August 2017

0 references

Gabriele Weitz-Schmidt

series ordinal

1

1 reference

5 August 2017

1 October 2002

1 reference

Trends in Pharmacological Sciences

5 August 2017

1 reference

5 August 2017

23

1 reference

5 August 2017

482-486

1 reference

5 August 2017

10

1 reference

Structural mechanism for statin inhibition of HMG-CoA reductase

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Pharmacology of competitive inhibitors of HMG-CoA reductase.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Protein prenylation: molecular mechanisms and functional consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Stimulation of bone formation in vitro and in rodents by statins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Statins as a newly recognized type of immunomodulator

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Statins for stroke: the second story?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Cardiovascular disease. Does inflammation cut to the heart of the matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Effects of pravastatin on chronic rejection of rat cardiac allografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Inhibition of monocyte chemotactic protein-1 synthesis by statins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Hmg-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: involvement of Rho GTPase-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Integrin-dependent leukocyte adhesion involves geranylgeranylated protein(s)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Cerivastatin suppresses lipopolysaccharide-induced ICAM-1 expression through inhibition of Rho GTPase in BAEC

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in pri

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Statins and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Modulation of inflammatory mediators and PPARgamma and NFkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Dbl and the Rho GTPases activate NF kappa B by I kappa B kinase (IKK)-dependent and IKK-independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Activators and target genes of Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

An isolated, surface-expressed I domain of the integrin alphaLbeta2 is sufficient for strong adhesive function when locked in the open conformation with a disulfide bond.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2802%2902077-1

7 January 2021

10.1016/S0165-6147(02)02077-1

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12368073